Paul Rivard is a principal shareholder of Banner & Witcoff in Washington, DC. This article reflects the opinion of the author and should not be attributed to the firm Banner & Witcoff or to any of its clients.
Appeals court paves the way for Patent and Trademark Office to adopt restrictive patent rules.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva